The Supreme Court has ruled against generic drugmaker
Mylan Inc. and other firms in their challenge of Teva Pharmaceutical
Industries' patents for a blockbuster multiple sclerosis drug.
The justices ruled 7-2 that a federal appeals court
wrongly overturned five of Teva's patents for the drug Copaxone, which
generates about $4 billion in annual sales for Teva. The majority told a lower
court to reconsider a ruling invalidating the patents.
Otosclerosis
Otosclerosis is an abnormal remodeling of bone near the middle ear that can cause hearing impairment. Otosclerosis usually affects the stapes bone, which rests its footplate exactly on the oval shaped membrane that covers the inner ear.
Advertisement
The decision allows the Israel-based company to keep its exclusive rights to Copaxone until September, delaying generic competition from Mylan and the other companies. And it gives Teva more time to shift patients to a longer acting version that won't face competition until 2030.
Source: Medindia
Tuberous Sclerosis
Tuberous sclerosis is genetic disorder characterized by benign tumors in many parts of the body, including brain, skin, lungs, kidney and heart.
Advertisement
 Amyotrophic Lateral Sclerosis (ALS)Find out more about the degenerative disease- Amyotrophic lateral sclerosis. | Advertisement
|
Multiple Sclerosis
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Advertisement
